Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: A prospective database study

被引:130
作者
Strasberg, SM
Dehdashti, F
Siegel, BA
Drebin, JA
Linehan, D
机构
[1] Washington Univ, Sch Med, Sect Hepatobiliary Pancreat Surg, Dept Surg, St Louis, MO USA
[2] Washington Univ, Sch Med, Div Nucl Med, Mallinckrodt Inst Radiol, St Louis, MO USA
关键词
D O I
10.1097/00000658-200103000-00001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To present the survival results for patients with colorectal carcinoma metastases who have undergone liver resection after being staged by [F-18] flouro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Summary Background Data Hepatic resection is standard therapy for colorectal metastases confined to the liver, but recurrence is common because of the presence of undetected cancer at the time of surgery. FDG-PET is a sensitive diagnostic tool that identifies tumors based on the increased uptake of glucose by tumor cells. To date, no survival results have been reported for patients who have actually had liver resection after being staged by FDG-PET. Methods Forty-three patients with metastatic colorectal cancer were referred for hepatic resection after conventional tumor staging with computed tomography. FDG-PET was performed on all patients. Laparotomy was performed on patients not staged out by PET. Resection was performed at the time of laparotomy unless extrahepatic disease or unresectable hepatic tumors were found. Patients were examined at intervals in the preoperative period. Results FDG-PET identified additional cancer not seen on computed tomography in 10 patients. Surgery was contraindicated in six of these patients because of the findings on FDG-PET. Laparotomy was performed in 37 patients. In ail but two, liver resection was peformed. Median follow-up in the 35 patients undergoing resection was 24 months. The Kaplan-Meier estimate of overall survival at 3 years was 77% and the lower 95% confidence limit of this estimate of survival was 60%. This figure is higher than 3-year estimate of survival found in previously published series. The 5-year disease-free survival rate was 40%. Conclusions Preoperative FDG-PET lessens the recurrence rate in patients undergoing hepatic resection for colorectal metastases to the liver by detection of disease not found on conventional imaging.
引用
收藏
页码:293 / 299
页数:7
相关论文
共 30 条
[1]   Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings [J].
Abdel-Nabi, H ;
Doerr, RJ ;
Lamonica, DM ;
Cronin, VR ;
Galantowicz, P ;
Carbone, GM ;
Spaulding, MB .
RADIOLOGY, 1998, 206 (03) :755-760
[2]   Determinants of survival following hepatic resection for metastatic colorectal cancer [J].
Bakalakos, EA ;
Kim, JA ;
Young, DC ;
Martin, EW .
WORLD JOURNAL OF SURGERY, 1998, 22 (04) :399-405
[3]   FDG PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features [J].
Berger, KL ;
Nicholson, SA ;
Dehdashti, F ;
Siegel, BA .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2000, 174 (04) :1005-1008
[4]   MAJOR HEPATIC RESECTION FOR COLORECTAL LIVER METASTASES [J].
BRADPIECE, HA ;
BENJAMIN, IS ;
HALEVY, A ;
BLUMGART, LH .
BRITISH JOURNAL OF SURGERY, 1987, 74 (04) :324-326
[5]  
Delbeke D, 1997, J NUCL MED, V38, P1196
[6]   100 PATIENTS WITH HEPATIC METASTASES FROM COLORECTAL-CANCER TREATED BY RESECTION - ANALYSIS OF PROGNOSTIC DETERMINANTS [J].
DOCI, R ;
GENNARI, L ;
BIGNAMI, P ;
MONTALTO, F ;
MORABITO, A ;
BOZZETTI, F .
BRITISH JOURNAL OF SURGERY, 1991, 78 (07) :797-801
[7]   DETERMINANTS OF SURVIVAL IN LIVER RESECTION FOR COLORECTAL SECONDARIES [J].
EKBERG, H ;
TRANBERG, KG ;
ANDERSSON, R ;
LUNDSTEDT, C ;
HAGERSTRAND, I ;
RANSTAM, J ;
BENGMARK, S .
BRITISH JOURNAL OF SURGERY, 1986, 73 (09) :727-731
[8]  
FEGIZ G, 1991, J SURG ONCOL, P144
[9]   Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer [J].
Flamen, P ;
Stroobants, S ;
Van Cutsem, E ;
Dupont, P ;
Bormans, G ;
De Vadder, N ;
Penninckx, F ;
Van Hoe, L ;
Mortelmans, L .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :894-901
[10]   Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer [J].
Flanagan, FL ;
Dehdashti, F ;
Ogunbiyi, OA ;
Kodner, IJ ;
Siegel, BA .
ANNALS OF SURGERY, 1998, 227 (03) :319-323